ArticleAmerican journal of cancer research2019

A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia.

Fengtao You et al.PubMed ↗Full text ↗

No numbers read from the abstract.